How Skincare OEM/ODM Can Use AI-Assisted Ingredient Discovery to Accelerate Product Development
In the age of generative AI, machine learning and big data, artificial intelligence is no longer changing only the way consumers search for and purchase beauty products.
It is also moving into one of the most important and technically demanding areas of the beauty industry:
Skincare research and development.
Traditionally, developing a new active ingredient can involve a long process of concept development, candidate screening, laboratory testing, formulation trials and repeated optimization before the ingredient is ready for commercialization.
With the rise of AI-Assisted Ingredient Discovery, however, researchers can now use computational tools to analyze large datasets, screen potential candidates and identify promising development directions much earlier in the R&D process.
For skincare brands, private-label businesses and emerging beauty companies, this development is more than a technological upgrade.
It represents a new approach to product innovation:
finding better opportunities earlier and turning them into differentiated products faster.
As a technology-oriented skincare development and manufacturing partner, Shine Biomed explores how AI is changing beauty R&D and how brands can combine emerging ingredient technologies with formulation expertise, advanced product formats and skincare OEM/ODM capabilities.
What Is AI-Assisted Ingredient Discovery?
AI-Assisted Ingredient Discovery refers to the use of machine learning, deep learning, bioinformatics, generative AI and computational modeling to analyze large amounts of molecular and biological data.
Depending on the research objective, these tools can help scientists evaluate:
molecular structures
peptide sequences
known biological activity
physicochemical properties
solubility
ingredient interactions
potential research candidates
Traditional ingredient discovery relies heavily on laboratory screening and repeated experimentation.
Researchers may begin with a large number of potential molecules, peptides, botanical compounds or other materials, then gradually test and eliminate candidates through experiments.
AI changes this process by allowing part of the early-stage screening to take place in a digital environment.
Through virtual screening and computational modeling, researchers can prioritize candidates that appear more relevant to a specific research objective before moving into laboratory testing.
In other words, AI does not replace scientific experiments.
Instead, it helps researchers answer an important question more efficiently:
Which candidates should we test first?
Traditional R&D vs. AI-Assisted R&D: How Is Ingredient Development Changing?
AI-assisted research is changing the beauty R&D process primarily by improving early-stage screening and decision-making.
Evaluation Area | Traditional Skincare R&D | AI-Assisted R&D |
Candidate Screening | Candidates are progressively evaluated through research experience and laboratory testing | Computational models can help narrow large candidate pools before testing |
Data Processing | Relies heavily on manual analysis and individual experiments | Large molecular and biological datasets can be analyzed more efficiently |
Formulation Exploration | Requires repeated physical prototyping and comparison | Certain formulation variables can be explored computationally before prototyping |
R&D Decision-Making | Large numbers of candidates are gradually eliminated | Higher-priority candidates can be identified earlier |
Development Model | Experiment-led | AI-assisted prediction combined with laboratory validation |
For beauty brands, the value is straightforward:
R&D resources can be focused on the directions that appear most promising.
This can reduce unnecessary early-stage trial and error while helping product teams make development decisions more efficiently.
Global Beauty Companies Are Already Investing in AI-Driven R&D
AI-assisted beauty research is no longer simply a future concept.
Major beauty groups and biotechnology companies are already integrating AI into ingredient and formulation research.
L’Oréal × NVIDIA: Moving Toward Predictive Beauty R&D
In March 2026, L’Oréal expanded its collaboration with NVIDIA to bring AI-powered computational chemistry into its Research & Innovation ecosystem.
Through NVIDIA's ALCHEMI machine-learning framework, researchers can model molecular behavior, ingredient interactions and formulation-related variables in a digital environment.
This allows scientists to explore multiple possibilities before moving into physical experimentation.
According to L’Oréal, the approach allows thousands of variables to be tested simultaneously and can make parts of the discovery process up to 100 times faster than conventional methods, with early work focused on areas such as photoprotection and skin tone.
The development represents an important shift in beauty technology:
AI is moving beyond ingredient discovery and into predictive formulation.
For the skincare industry, this means future R&D may increasingly combine computational modeling with traditional formulation science.
AI Platforms Are Expanding the Search for New Beauty Ingredients
Beauty biotechnology companies are also using AI to explore much larger libraries of potential ingredients than would be practical through traditional experimental screening alone.
By combining biological datasets, computational models and biotechnology, researchers can identify promising candidates and then move the most relevant options into laboratory testing and product development.
This emerging model can be summarized as:
AI discovery → scientific validation → formulation → commercialization.
For brands, the important takeaway is not the size of a particular molecular database.
It is that AI gives researchers a more efficient way to explore a much broader range of possibilities before committing significant development resources.
LG Household & Health Care: AI-Assisted Ingredient Screening in Asia
AI-driven beauty research is also gaining momentum in Asia.
LG Household & Health Care has worked with LG AI Research to apply the EXAONE Discovery model to cosmetic ingredient development.
The technology is designed to help research teams analyze molecular information and identify promising candidates more efficiently during the early stages of development.
In one reported case, the model screened more than 420,000 candidate compounds in a single day — a screening stage the company had previously estimated at close to two years — and identified an ingredient subsequently named Rhamsydil.
This illustrates one of the clearest strengths of AI-assisted research:
rapidly narrowing the search space before laboratory validation.
Instead of treating AI as a replacement for scientists, beauty companies are increasingly using it to make the research process more focused and data-driven.
Four Key Applications of AI in Skincare R&D
1. Active Ingredient and Peptide Candidate Screening
One of the most important applications of AI in beauty research is the screening of potential active ingredients.
Peptides are a particularly good example.
There are an enormous number of possible peptide sequences, making comprehensive laboratory screening extremely time-consuming.
AI models can help researchers analyze candidate peptides based on factors such as:
molecular structure
peptide sequence
existing biological data
physicochemical characteristics
solubility
stability-related information
Researchers can then prioritize a smaller group of candidates for further testing.
This creates a more efficient development model:
AI helps identify promising directions, while laboratory research validates the results.
For beauty brands, this also creates more opportunities to explore next-generation peptide and biotech ingredient concepts.
2. Predictive Formulation and Ingredient Compatibility
In skincare OEM/ODM development, finding an interesting ingredient is only the beginning.
The next challenge is turning it into a stable, appealing formulation.
Common formulation issues include:
emulsion instability
separation
discoloration
undesirable texture
ingredient incompatibility
pH limitations
repeated prototype adjustments
Predictive formulation tools can analyze formulation data, ingredient properties and previous experimental results to help researchers identify more promising combinations before physical prototyping begins.
This does not eliminate stability testing or formulation trials.
Instead, it can help formulation teams begin from a better-informed starting point.
For skincare OEM/ODM manufacturers, this may become one of the most valuable applications of AI:
reducing unnecessary prototyping and improving formulation decision-making.
3. Early-Stage Safety Screening
Safety remains an essential part of cosmetic ingredient and product development.
Computational methods can support early-stage screening by helping researchers identify candidates that may require additional attention before further development.
One example is QSAR — Quantitative Structure–Activity Relationship modeling.
QSAR models analyze relationships between molecular structures and existing data to support the initial evaluation of candidate ingredients.
This allows research teams to prioritize appropriate candidates for subsequent testing and assessment.
The value of AI here is not to replace established safety evaluation procedures.
It is worth being precise about where computational screening sits in the regulatory picture. In silico output such as QSAR results is supporting evidence used to prioritise candidates and justify a testing strategy; it does not replace the safety assessment a product dossier requires. In the EU, a Product Information File must still carry a safety assessment signed by a qualified safety assessor, and Taiwan likewise requires a product information file with safety data signed by a qualified person. AI can make the evidence-gathering more efficient, but the assessment and the signature remain human responsibilities.
This is also where Shine Biomed applies AI to its own work. Compiling a toxicological profile means pulling together published studies, supplier dossiers and database entries for every ingredient in a formula, then cross-checking them for gaps and inconsistencies — work that is slow but largely mechanical.
Shine Biomed's in-house safety assessor uses AI-assisted tools for that collection and cross-referencing stage, which shortens the document preparation that sits behind a Product Information File. The judgement on what the evidence means, and the signature on the assessment, remain with the qualified assessor.
Rather, it allows teams to make more informed decisions earlier in the research process.
4. AI + Biotechnology: Developing the Next Generation of Beauty Ingredients
Another important trend is the integration of AI with biotechnology and advanced biological manufacturing.
Researchers are increasingly using computational tools to explore and design:
peptides
proteins
biomimetic materials
biotechnology-derived ingredients
new functional materials
These candidates can then be produced through fermentation, precision fermentation or other biotechnology processes.
This combination of AI-assisted discovery + biotech manufacturing opens new possibilities for beauty innovation.
Instead of beginning only with an existing botanical extract or conventional ingredient library, researchers can start with a specific development objective and use computational tools to identify potential solutions.
For brands, this also creates a new kind of product story.
Beauty innovation is gradually moving from:
“Where did this rare ingredient come from?”
to:
“How was this ingredient discovered and developed?”
AI Is Changing Skincare R&D — But Formulation Still Matters
AI can help researchers process large amounts of information, identify patterns and prioritize promising development directions.
However, transforming an ingredient into a successful skincare product still requires extensive formulation expertise.
Product development must still consider:
formulation design
texture
sensory experience
stability
packaging compatibility
production processes
scale-up
quality consistency
This is why the growth of AI does not reduce the importance of skincare OEM/ODM expertise.
In fact, it makes strong formulation and manufacturing capabilities even more valuable.
AI can help identify an opportunity. Formulation and manufacturing turn that opportunity into a real product.
From AI Ingredient Discovery to Skincare OEM/ODM: What Does It Mean for Brands?
Most beauty brands do not need to develop their own AI ingredient discovery platforms.
The more important impact is happening throughout the upstream beauty supply chain.
As ingredient suppliers, biotechnology companies and research organizations adopt AI, brands are likely to gain access to a growing range of:
new peptides, biotech ingredients, fermentation-derived materials, formulation technologies and advanced product concepts.
The key challenge therefore shifts from simply finding new ingredients to deciding:
Which innovations are worth turning into products?
This is where a technology-oriented skincare OEM/ODM partner can create value.
The next generation of skincare development will increasingly depend on the ability to integrate:
new ingredients × formulation expertise × advanced product formats × manufacturing capabilities.
Shine Biomed: Technology-Driven Skincare Product Development
As AI, biotechnology and beauty ingredient innovation continue to evolve, brands are facing more development opportunities than ever.
New ingredients emerge faster.
Product formats continue to evolve.
Consumers also expect skincare products to deliver both a compelling concept and a refined user experience.
Founded in July 2023, Shine Biomed brings together teams from the beauty industry and from precision technology — combining cosmetic formulation and manufacturing experience with a background in microelectronics, precision materials and microfluidics — and integrates that into skincare product development.
Rather than focusing only on standard OEM manufacturing, Shine Biomed places greater emphasis on:
formulation development, distinctive product formats and commercialization.
MPM Molecular Polymer Membrane: Creating New Skincare Formats Through Materials Technology
Shine Biomed's MPM Molecular Polymer Membrane is formed by ionically crosslinking several hydrophilic polymers (polysaccharides) into a flexible, skin-friendly gel membrane with excellent conformability.
The technology can be developed into a range of skincare formats, including:
full-face moisturizing masks
eye masks
neck masks
localized skincare patches
zone-specific skincare products
Compared with conventional sheet formats, the membrane itself can become an important part of the product experience.
For brands, this creates opportunities to differentiate not only through ingredients, but also through:
material, format and application experience.
As high-performance skincare becomes increasingly competitive, these tangible product differences can help strengthen brand recognition.
Microfluidic Technology: Making Beauty Technology Visible
Another technology suited to science-driven skincare development is microfluidics.
Through controlled microfluidic processing, an oil phase can be formed into droplets of a controlled, uniform size and dispersed within a water-based essence or serum, with the oil-phase ratio adjustable to suit the product positioning.
This creates several advantages for product development.
1. Strong Visual Identity
The droplets remain visible inside the bottle, giving the formulation an immediate visual signature.
For brands, this can help create a distinctive product appearance suitable for technology-driven, premium and social-media-oriented skincare concepts.
2. Flexible Oil-and-Water Formulation Design
The aqueous phase can be designed around ingredients such as:
hyaluronic acid
niacinamide
humectants
water-soluble botanical extracts
The oil phase can incorporate:
botanical oils
lipids
oil-soluble vitamins
oil-soluble antioxidant ingredients
This gives formulation teams more flexibility when designing layered skincare concepts.
3. A Refined Sensory Experience
During application, the droplets blend with the aqueous serum.
Depending on the formulation, the product can be designed to deliver a texture that feels:
lightweight, smooth and moisturizing without excessive heaviness.
In this way, microfluidic technology does not remain hidden behind technical terminology.
It becomes:
a product feature that consumers can see and experience.
CrystalGuide Encapsulation Platforms and Microcrystal Patches
Microfluidic droplet control is one of three encapsulation platforms Shine Biomed groups under CrystalGuide. Crystal Bead forms visible capsules by ionically crosslinking natural polysaccharides with metal ions, holding the active in the core of the bead; Shine Biomed has filed invention and utility model patent applications covering the bead structure and its preparation method.
Crystal Glow uses microfluidic control to suspend oil droplets in an aqueous serum. Crystal Cell extends the same approach to solid lipid particles and water-in-oil dual-core structures. The three differ in encapsulation difficulty, appearance and cost, so the choice should follow the product positioning and budget.
Alongside these, microcrystal patches combine fine crystalline structures with a patch carrier for localised areas such as the eye contour and the nasolabial fold, which suits single-use packaging, cycle-based regimens or sets paired with a serum. Where such patches are developed as cosmetics, the product design and copy should avoid implying penetration of the stratum corneum, delivery into the dermis or injection.
How AI Is Changing the Role of Skincare OEM/ODM Partners
Traditionally, brands choosing a skincare manufacturer often focused on three questions:
What is the price? What is the MOQ? Do you have an existing formula?
In the AI era, another question is becoming increasingly important:
Can this OEM/ODM partner understand emerging technologies and turn them into commercially viable products?
As upstream ingredient innovation accelerates, skincare manufacturers will increasingly need to combine market awareness with strong product-development capabilities.
Three areas will become particularly important.
1. Evaluating Emerging Ingredients and Technologies
New biotech ingredients, AI-assisted research concepts and advanced formulation technologies are appearing rapidly.
Not every trend needs to become a product.
The ability to evaluate product positioning, formulation feasibility and market relevance is therefore an important part of modern skincare development.
2. Integrating Ingredients, Formulation and Product Format
Trending ingredients are relatively easy for competitors to follow.
What is harder to replicate is the complete product experience created by:
ingredient + formulation + texture + product format.
This is where distinctive technologies such as membrane materials and microfluidic formulations can create additional differentiation.
3. Turning Concepts Into Market-Ready Products
Brands ultimately do not need another research concept.
They need a product that can move through:
concept → formulation → prototype → testing → packaging → manufacturing.
An integrated OEM/ODM development process can help reduce coordination across multiple suppliers and make it easier for brands to transform emerging beauty trends into commercially viable products.
Quality systems matter at this stage as well. Shine Biomed's manufacturing complies with Taiwan's cosmetic GMP requirements and is certified to ISO 22716 and ISO 9001. ISO 22716 is the international standard for cosmetic good manufacturing practice and the harmonised reference for the GMP requirement under EU Regulation (EC) No 1223/2009, which makes it directly useful as supporting documentation for brands exporting to the EU and ASEAN markets.
Shine Biomed also has an in-house cosmetic safety assessor and can compile the Product Information File alongside formulation and manufacturing work, using AI-assisted tools to speed up the toxicological data gathering behind it.
AI Skincare R&D FAQ
What is AI-assisted ingredient discovery?
AI-assisted ingredient discovery uses machine learning, computational modeling and biological data analysis to help researchers screen large numbers of potential ingredients and prioritize promising candidates for further testing.
Its primary role is to improve early-stage research efficiency.
Can AI be used to develop skincare ingredients?
Yes.
AI is increasingly being used for candidate screening, peptide research, molecular analysis and predictive formulation.
Major beauty companies and biotechnology firms have already begun integrating these tools into their research processes.
Can AI replace laboratory testing?
No.
AI can assist with screening, prediction and research prioritization, but laboratory testing, formulation development, stability evaluation and product validation remain essential.
The most useful way to understand the technology is:
AI supports and accelerates R&D rather than replacing it.
How Can AI Accelerate Skincare Product Development?
AI can help researchers analyze large datasets, narrow candidate pools and identify promising formulation directions earlier.
Its impact varies depending on the ingredient, available data and development process, but its key advantage is improving early-stage screening and research decision-making.
Can Small Beauty Brands Benefit From AI-Driven Skincare Innovation?
Yes.
Brands do not need to build their own AI research platforms.
As ingredient suppliers and biotechnology companies integrate AI into their development processes, smaller brands can access emerging ingredients and technologies through their skincare OEM/ODM supply chain.
The more important question is:
How can those innovations be translated into a product that fits the brand and its target market?
Does Shine Biomed use AI in its own development work?
Yes, in a defined role. Shine Biomed's in-house safety assessor uses AI-assisted tools to gather and cross-check toxicological data when compiling a Product Information File, which shortens the document preparation stage. Formulation decisions, the safety evaluation itself and the signature on a safety assessment remain with the responsible people, and AI output is not presented as a substitute for laboratory testing or for a qualified assessment.
Conclusion: AI Is Accelerating Beauty Innovation — Product Development Turns It Into Market Value
AI-assisted ingredient discovery is beginning to reshape the underlying structure of skincare R&D.
From ingredient screening and peptide research to predictive formulation and biotechnology, beauty development is becoming an increasingly interdisciplinary process combining:
data science × biotechnology × formulation engineering × consumer experience.
For skincare brands, the opportunity is not simply to add “AI” to a product story.
The real value lies in using new research capabilities and a more advanced beauty supply chain to identify:
promising ingredients, distinctive product formats and stronger development opportunities.
Shine Biomed combines formulation development, MPM Molecular Polymer Membrane technology, the CrystalGuide encapsulation platforms, microcrystal patches and integrated OEM/ODM manufacturing — under Cosmetic GMP, ISO 22716 and ISO 9001 — to help brands translate emerging beauty technologies into differentiated skincare products.
If you are planning to develop:
technology-driven skincare, high-performance serums, peptide products, biotech-inspired skincare, microfluidic essences, visible-capsule serums, microcrystal patches or specialized membrane products,
Shine Biomed can support product positioning, formulation planning, product format development and manufacturing based on your brand strategy and target market.
AI can help R&D find promising directions faster. The real competitive advantage comes from turning those directions into products consumers want to use.
